| Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS (NCT05204017) | University of Alberta | 2021-09-12 |
| Phenotype, Genotype and Biomarkers 2 (NCT04875416) | University of Miami | 2021-01-08 |
| TRIAL READY (Clinical Trial Readiness) (NCT03912987) | University of Miami | 2019-01-22 |
| Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS) (NCT03560661) | Assistance Publique - Hôpitaux de Paris | 2018-07-05 |
| Clinical Procedures to Support Research in ALS (NCT03489278) | University of Miami | 2018-02-15 |
| A Patient Centric Motor Neuron Disease Activities of Daily Living Scale (NCT02852278) | University of South Florida | 2016-12-01 |
| Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease (NCT03067857) | Stem Cells Arabia | 2016-09-01 |
| Answer ALS: Individualized Initiative for ALS Discovery (NCT02574390) | Johns Hopkins University | 2015-12-01 |
| Imaging Biomarkers in ALS (NCT02567136) | University of Minnesota | 2015-09-01 |
| Phenotype, Genotype & Biomarkers in ALS and Related Disorders (NCT02327845) | University of Miami | 2015-04-01 |
| Oxidative Stress in Motor Neuron Disease: COSMOS Add-On Study (NCT01143428) | National Institute of Neurological Disorders and Stroke (NINDS) | 2010-05-13 |
| Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease (NCT00324454) | Duke University | 2006-05-01 |
| Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis (NCT00023075) | National Institute of Neurological Disorders and Stroke (NINDS) | 2001-08-01 |
| Screening and Natural History: Primary Lateral Sclerosis and Related Disorders (NCT00015444) | National Institute of Neurological Disorders and Stroke (NINDS) | 2001-05-01 |